The earliest prenatal DNA test available is a non-invasive paternity test, which can be done as early as 8 weeks of pregnancy. If you’re looking for genetic screening to check for chromosomal conditions like Down syndrome, that becomes available at 10 weeks. Diagnostic procedures that provide definitive genetic answers start at 11 weeks. The right timing depends on what kind of DNA test you need and why.
Paternity Testing: Available at 8 Weeks
A non-invasive prenatal paternity test (NIPP) can be performed as early as the eighth week of pregnancy using a simple blood draw from the mother. By that point, enough of the baby’s DNA is circulating in the mother’s bloodstream to compare against a potential father’s DNA sample. The test is 99.9% accurate, according to Cleveland Clinic, and carries no risk to the pregnancy because it only requires a blood sample from the mother’s arm.
Earlier paternity tests required invasive procedures like amniocentesis, which meant waiting until at least 15 weeks and accepting a small risk of miscarriage. Blood-based paternity testing eliminated that tradeoff. Results typically come back within one to two weeks.
NIPT Screening: Available at 10 Weeks
Non-invasive prenatal testing, commonly called NIPT, screens for chromosomal conditions by analyzing fragments of the baby’s DNA floating in the mother’s blood. It can be done starting at 10 weeks of pregnancy. Before that point, there generally isn’t enough fetal DNA in your bloodstream for the lab to produce a reliable result.
NIPT screens for trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), trisomy 13 (Patau syndrome), and sex chromosome differences. For Down syndrome specifically, the test detects 99.3% of cases and has a specificity of 99.9%, meaning false positives are rare. Most NIPT panels also reveal the baby’s sex, which is one reason some parents opt for it even when they’re at low risk for chromosomal conditions.
The test itself is straightforward: a single blood draw from your arm, with results typically returning within 7 to 10 days. NIPT is a screening test, not a diagnostic one. A high-risk result doesn’t confirm a condition. It means further testing, usually amniocentesis or CVS, is recommended to get a definitive answer.
When Results Come Back Inconclusive
A small percentage of NIPT tests come back with no result because the fetal DNA concentration in the blood sample (called fetal fraction) was too low for the lab to analyze. This is more common in women with a higher BMI, because a larger blood volume dilutes the concentration of fetal DNA. A large study of over 153,000 pregnancies confirmed that fetal fraction decreases as maternal BMI increases. Fetal fraction also rises as pregnancy progresses, so if your first test fails, repeating it one to two weeks later often solves the problem.
CVS: Available at 11 Weeks
Chorionic villus sampling is the earliest diagnostic test available during pregnancy, performed between 11 and 13 weeks (and sometimes up to 14 weeks). Unlike NIPT, CVS provides a definitive diagnosis rather than a risk estimate. It works by collecting a tiny sample of tissue from the placenta, which shares the baby’s genetic makeup.
CVS is typically offered when NIPT returns a high-risk result, when an ultrasound reveals a concern, or when parents have a known genetic condition in the family. Because it’s invasive, it carries a small additional miscarriage risk of less than 0.5% when performed by an experienced provider. For twin pregnancies, that risk is around 1%. The procedure should not be done before 10 weeks of gestation.
One practical advantage of CVS over amniocentesis is timing. If you might consider ending the pregnancy based on results, CVS gives you more time to make that decision. The American College of Obstetricians and Gynecologists notes that termination is safer before 13 weeks, which makes the earlier window of CVS relevant for some families.
Amniocentesis: Available at 15 Weeks
Amniocentesis is the other diagnostic option, usually performed between 15 and 20 weeks of pregnancy, though it can technically be done up until delivery. The procedure draws a small amount of amniotic fluid, which contains fetal cells that can be analyzed for chromosomal abnormalities, genetic disorders, and other conditions. Like CVS, it carries an additional miscarriage risk below 0.5% with a skilled provider.
Amniocentesis is often chosen over CVS when testing is needed later in pregnancy, when CVS isn’t available locally, or when the specific genetic question is better answered by analyzing amniotic fluid. Some conditions can only be tested through amniocentesis rather than CVS.
Choosing the Right Test and Timing
Your timeline depends on what you’re trying to learn. If the question is paternity, 8 weeks is the earliest you can test. If you want to screen for common chromosomal conditions with minimal risk, NIPT at 10 weeks is the standard starting point. If you need a confirmed genetic diagnosis as early as possible, CVS at 11 weeks is the first available option.
Many parents follow a staged approach: NIPT first as an early screen, followed by CVS or amniocentesis only if the screening flags something. This avoids the small procedural risks of invasive testing unless there’s a reason to pursue a definitive answer. Others with a family history of genetic conditions or previous affected pregnancies may skip straight to diagnostic testing.
Keep in mind that each test has its own result turnaround time, usually one to two weeks. If early results matter to you, factor that wait into your planning. Getting your blood drawn for NIPT at exactly 10 weeks, for example, means you’d likely have screening results by 11 or 12 weeks.